Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRIDEX CORP Director's Dealing 2014

Aug 16, 2014

34978_dirs_2014-08-15_fc105907-6c1f-4d63-8b97-3d7ebe4358f3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2014-08-13

Reporting Person: HAWKINS JAMES B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-13 Common Stock M 9786 $4.86 Acquired 41080 Direct
2014-08-13 Common Stock S 9786 $8.1081 Disposed 31294 Direct
2014-08-14 Common Stock M 2714 $4.86 Acquired 34008 Direct
2014-08-14 Common Stock S 2714 $8.0812 Disposed 31294 Direct
2014-08-15 Common Stock M 1900 $4.86 Acquired 33194 Direct
2014-08-15 Common Stock S 1900 $8.0703 Disposed 31294 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-13 Stock Option Right to Buy $4.86 M 9786 Disposed 2014-10-31 Common Stock (9786) Direct
2014-08-14 Stock Option Right to Buy $4.86 M 2714 Disposed 2014-10-31 Common Stock (2714) Direct
2014-08-15 Stock Option Right to Buy $4.86 M 1900 Disposed 2014-10-31 Common Stock (1900) Direct

Footnotes

F1: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $8.10 to $8.1375 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2: The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $8.00 to $8.135 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $8.00 to $8.09 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F4: This option was granted pursuant to IRIDEX Corporation's incentive 1998 Stock Plan and is exempt pursuant to Rule 16b-3.

F5: Shares subject to the option are fully vested and immediately exercisable.